Cost-effectiveness of eformoterol Turbohaler® versus salmeterol Accuhaler® in children with symptomatic asthma

This publication has 14 references indexed in Scilit:

• Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μ g twice daily and budesonide 800 μ g twice daily in the treatment of adults and adolescents with asthma
  Respiratory Medicine, 2000
• The burden of childhood asthma
  Archives of Disease in Childhood, 2000
• Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects
  Thorax, 2000
• Risk factors and costs associated with an asthma attack
  Thorax, 2000
• A cost analysis on the pattern of asthma prescribing in the UK
  European Respiratory Journal, 1999
• The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children
  Respiratory Medicine, 1999
• Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
  PharmacoEconomics, 1998
• Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children
  Thorax, 1997
• National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma Care
  American Journal of Respiratory and Critical Care Medicine, 1996
• The Episode-Free Day as a Composite Measure of Effectiveness
  PharmacoEconomics, 1993